These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17619565)
21. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
22. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chetta A; Foresi A; Del Donno M; Bertorelli G; Pesci A; Olivieri D Chest; 1997 Apr; 111(4):852-7. PubMed ID: 9106559 [TBL] [Abstract][Full Text] [Related]
23. A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials. Fuhlbrigge AL; Bengtsson T; Peterson S; Jauhiainen A; Eriksson G; Da Silva CA; Johnson A; Sethi T; Locantore N; Tal-Singer R; Fagerås M Lancet Respir Med; 2017 Jul; 5(7):577-590. PubMed ID: 28583396 [TBL] [Abstract][Full Text] [Related]
24. The impact of bronchiectasis in clinical presentation of asthma. Oguzulgen IK; Kervan F; Ozis T; Turktas H South Med J; 2007 May; 100(5):468-71. PubMed ID: 17534081 [TBL] [Abstract][Full Text] [Related]
25. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. Kang HR; Song HJ; Nam JH; Hong SH; Yang SY; Ju S; Lee SW; Kim TB; Kim HL; Lee EK BMJ Open; 2018 Mar; 8(3):e020825. PubMed ID: 29567854 [TBL] [Abstract][Full Text] [Related]
26. Ischemia-modified albumin levels in children with asthma: a pilot study. Dogru M; Akoglu H; Kilinckaya MF; Ulfer G Arch Argent Pediatr; 2018 Aug; 116(4):e522-e528. PubMed ID: 30016026 [TBL] [Abstract][Full Text] [Related]
27. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma. Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951 [TBL] [Abstract][Full Text] [Related]
28. Sputum neurokinin A in Egyptian asthmatic children and adolescents: relation to exacerbation severity. Mostafa GA; Reda SM; Abd El-Aziz MM; Ahmed SA Allergy; 2008 Sep; 63(9):1244-7. PubMed ID: 18507649 [TBL] [Abstract][Full Text] [Related]
29. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. Sposato B; Scalese M; Latorre M; Scichilone N; Matucci A; Milanese M; Masieri S; Rolla G; Steinhilber G; Rosati Y; Vultaggio A; Folletti I; Baglioni S; Bargagli E; Di Tomassi M; Pio R; Pio A; Maccari U; Maggiorelli C; Migliorini MG; Vignale L; Pulerà N; Carpagnano GE; Foschino Barbaro MP; Perrella A; Paggiaro PL Respir Med; 2016 Oct; 119():141-149. PubMed ID: 27692136 [TBL] [Abstract][Full Text] [Related]
31. [Exacerbations in severe persistent asthma--impact of risk factors control]. Ferreira D; Duarte R; Carvalho A Rev Port Pneumol; 2007; 13(5):675-89. PubMed ID: 17962886 [TBL] [Abstract][Full Text] [Related]
32. The Totton-Ken Seibu earthquake and exacerbation of asthma in adults. Tomita K; Hasegawa Y; Watanabe M; Sano H; Hitsuda Y; Shimizu E J Med Invest; 2005 Feb; 52(1-2):80-4. PubMed ID: 15751277 [TBL] [Abstract][Full Text] [Related]
33. A computerized asthma-specific quality of life: a novel tool for reflecting asthma control and predicting exacerbation. Kim MA; Ye YM; Park JW; Lee JH; Lee SK; Kim CW; Jung KS; Kim JH; Yoo HS; Kim SH; Shin YS; Nahm DH; Park HS; Int Arch Allergy Immunol; 2014; 163(1):36-42. PubMed ID: 24247849 [TBL] [Abstract][Full Text] [Related]
34. Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Gouge SF; Daniels DJ; Smith CE Mil Med; 1994 Feb; 159(2):108-11. PubMed ID: 8202234 [TBL] [Abstract][Full Text] [Related]
35. Predicting changes in clinical status of young asthmatics: clinical scores or objective parameters? Leung TF; Ko FW; Wong GW; Li CY; Yung E; Hui DS; Lai CK Pediatr Pulmonol; 2009 May; 44(5):442-9. PubMed ID: 19382219 [TBL] [Abstract][Full Text] [Related]
36. Delayed kinetics of phagocytosis related respiratory burst in blood is a distinctive feature of moderate exacerbation of bronchial asthma. Tikhonova IV; Grinevich AA; Kosyakova NI; Safronova VG Free Radic Biol Med; 2019 Apr; 134():327-334. PubMed ID: 30685404 [TBL] [Abstract][Full Text] [Related]
37. [Role of serum S1P levels during asthma attack in the evaluation of asthma severity]. Zhao Y; Xu Y; Li S; Wei Y; Wang C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):794-798. PubMed ID: 28936954 [TBL] [Abstract][Full Text] [Related]
38. Airway inflammation and bronchial hyperreactivity in steroid naive children with intermittent and mild persistent asthma. Toyran M; Bakirtas A; Dogruman-Al F; Turktas I Pediatr Pulmonol; 2014 Feb; 49(2):140-7. PubMed ID: 23798479 [TBL] [Abstract][Full Text] [Related]
39. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785 [TBL] [Abstract][Full Text] [Related]
40. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study. Brusselle G; Michils A; Louis R; Dupont L; Van de Maele B; Delobbe A; Pilette C; Lee CS; Gurdain S; Vancayzeele S; Lecomte P; Hermans C; MacDonald K; Song M; Abraham I Respir Med; 2009 Nov; 103(11):1633-42. PubMed ID: 19619998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]